Hyalgan 20 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG3BM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,647
Award facts
- Contract value 100% obligated
- $1,646.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,646.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Hyalgan 20 mg/2 mL syringes on January 8, 2026, with an ultimate completion date of January 9, 2026. This non-set-aside contract represents a small-value pharmaceutical delivery executed through the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a subsidiary of Cencora, Inc., and serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems.
This delivery order falls under AmerisourceBergen's larger $999,999,999 indefinite delivery contract with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and provides comprehensive global pharmaceutical support for military healthcare programs. The parent company, Cencora, Inc., maintains an even larger IDC valued at up to $999,999,999 through December 31, 2031, underscoring the company's substantial role in the federal pharmaceutical supply chain. Hyalgan, a hyaluronic acid-based injectable treatment commonly used for knee osteoarthritis, represents one of many specialty pharmaceutical products the contractor supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FG3BM?
SPE2DR26FG3BM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FG3BM worth?
The government has obligated $1,647 on SPE2DR26FG3BM.
Is contract SPE2DR26FG3BM an order under another contract?
Yes. SPE2DR26FG3BM is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3BM competed?
The extent of competition for SPE2DR26FG3BM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award